Annual Reports

Quarterly Reports


  • 8-K (May 4, 2016)
  • 8-K (Apr 14, 2016)
  • 8-K (Mar 31, 2016)
  • 8-K (Mar 1, 2016)
  • 8-K (Jan 19, 2016)
  • 8-K (Jan 11, 2016)


Medtronic 8-K 2012

Documents found in this filing:

  1. 8-K
  2. 8-K
Form 8-K





Washington, DC 20549






Current Report

Pursuant to Section 13 OR 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 16, 2012



Medtronic, Inc.

(Exact name of registrant as specified in its charter)




Minnesota   1-07707   41-0793183

(State or other jurisdiction

of incorporation)



File Number)


(IRS Employer

Identification No.)

710 Medtronic Parkway,

Minneapolis MN

(Address of principal executive offices)   (Zip Code)

(763) 514-4000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

(17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

(17 CFR 240.13e-4(c))




Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 16, 2012, David L. Calhoun notified Medtronic, Inc. (the “Company”) that he would not stand for reelection to the Board of Directors of the Company at the 2012 annual meeting of shareholders, due to his other board and executive commitments. Mr. Calhoun’s decision not to pursue reelection was not due to a disagreement with the Company. Mr. Calhoun will continue to serve as a director of the Company until the expiration of his term at the 2012 annual meeting of shareholders.


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  By   /s/ D. Cameron Findlay


Date: February 22, 2012

    D. Cameron Findlay
    Senior Vice President and General Counsel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki